Role of ubiquitin in parainfluenza virus 5 particle formation

Journal of Virology

Volumn 86, Issue 7, 2012, Pages 3474-3485

  Harrison, Megan S ^a,b   Schmitt, Phuong Tieu ^a   Pei, Zifei ^a   Schmitt, Anthony P ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HN PROTEIN; LYSINE; MATRIX PROTEIN; NUCLEOCAPSID PROTEIN; PROTEASOME INHIBITOR; UBIQUITIN;

ALGORITHM; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; GENETIC TRANSFECTION; MAMMAL CELL; MASS SPECTROMETRY; MUTAGENESIS; NONHUMAN; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS 5; PRIORITY JOURNAL; UBIQUITINATION; VIROGENESIS; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS LIKE AGENT; VIRUS LOAD; VIRUS MUTATION; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS RELEASE; WILD TYPE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CELL LINE; HUMANS; MOLECULAR SEQUENCE DATA; RUBULAVIRUS INFECTIONS; SIMIAN VIRUS 5; UBIQUITIN; UBIQUITINATION; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY; VIRUS RELEASE;

MAMMALIA; PARAINFLUENZA VIRUS; PARAMYXOVIRIDAE;

EID: 84861309987     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06021-11     Document Type: Article

References (63)

1. Anckar J, Sistonen L. 2007. SUMO: getting it on. Biochem. Soc. Trans. 35: 1409 -1413.
2. Bess JW, Jr, Gorelick RJ, Bosche WJ, Henderson LE, Arthur LO. 1997. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology 230: 134 -144.
3. Bouamr F, et al. 2003. PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101. J. Virol. 77: 11882-11895.
4. Cosson P, Letourneur F. 1994. Coatomer interaction with di-lysine endoplasmic reticulum retention motifs. Science 263: 1629 -1631.
5. Gluschankof P, Mondor I, Gelderblom HR, Sattentau QJ. 1997. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology 230: 125-133.
6. Gottwein E, Jager S, Habermann A, Krausslich HG. 2006. Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 Gag cause a late budding defect. J. Virol. 80: 6267- 6275.
7. Gottwein E, Krausslich HG. 2005. Analysis of human immunodeficiency virus type 1 Gag ubiquitination. J. Virol. 79: 9134 -9144.
8. Haglund K, Dikic I. 2005. Ubiquitylation and cell signaling. EMBO J. 24: 3353-3359.
9. Harrison MS, Sakaguchi T, Schmitt AP. 2010. Paramyxovirus assembly and budding: building particles that transmit infections. Int. J. Biochem. Cell Biol. 42: 1416 -1429.
10. Harty RN, et al. 2001. Rhabdoviruses and the cellular ubiquitinproteasome system: a budding interaction. J. Virol. 75: 10623-10629.
11. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP. 2000. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. U. S. A. 97: 13871-13876.
12. He B, Lin GY, Durbin JE, Durbin RK, Lamb RA. 2001. The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J. Virol. 75: 4068-4079.
13. He B, Paterson RG, Ward CD, Lamb RA. 1997. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237: 249-260.
14. Heidecker G, Lloyd PA, Soheilian F, Nagashima K, Derse D. 2007. The role of WWP1-Gag interaction and Gag ubiquitination in assembly and release of human T-cell leukemia virus type 1. J. Virol. 81: 9769 -9777.
15. Hershko A, Ciechanover A, Varshavsky A. 2000. The ubiquitin system. Nat. Med. 6: 1073-1081.
16. Hicke L, Dunn R. 2003. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell Dev. Biol. 19: 141-172.
17. Horvath CM. 2004. Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur. J. Biochem. 271: 4621- 4628.
18. Joshi A, Munshi U, Ablan SD, Nagashima K, Freed EO. 2008. Functional replacement of a retroviral late domain by ubiquitin fusion. Traffic 9: 1972-1983.
19. Kaiser P, Wohlschlegel J. 2005. Identification of ubiquitination sites and determination of ubiquitin-chain architectures by mass spectrometry, p 266-276. In Deshaies RJ (ed), Ubiquitin and protein degradation, part B, vol 399. Elsevier Academic Press, San Diego, CA.
20. Kirkpatrick DS, Denison C, Gygi SP. 2005. Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics. Nat. Cell Biol. 7: 750 -757.
21. Lamb RA, Parks GD. 2006. Paramyxoviridae: the viruses and their replication, p 1449-1496. In Knipe DM, et al (ed), Fields virology, 5th ed. Lippincott, Williams & Wilkins, Philadelphia, PA.
22. Le Blanc I, Rosenberg AR, Dokhelar MC. 1999. Multiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmission. J. Virol. 73: 1860 -1867.
23. Liao TL, Wu CY, Su WC, Jeng KS, Lai MM. 2010. Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication. EMBO J. 29: 3879 -3890.
24. Lim KL, et al. 2005. Parkin mediates nonclassical, proteasomalindependent ubiquitination of synphilin-1: implications for Lewy body formation. J. Neurosci. 25: 2002-2009.
25. Malakhova OA, Zhang D-E. 2008. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J. Biol. Chem. 283: 8783-8787.
26. Marfori M, et al. 2011. Molecular basis for specificity of nuclear import and prediction of nuclear localization. Biochim. Biophys. Acta 1813: 1562-1577.
27. Martin-Serrano J. 2007. The role of ubiquitin in retroviral egress. Traffic 8: 1297-1303.
28. Morita E, Sundquist WI. 2004. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20: 395- 425.
29. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 108: 193- 199.
30. Okumura A, Pitha PM, Harty RN. 2008. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl. Acad. Sci. U. S. A. 105: 3974 -3979.
31. Olver C, Vidal M. 2007. Proteomic analysis of secreted exosomes. Subcell. Biochem. 43: 99 -131.
32. Ott DE, Coren LV, Chertova EN, Gagliardi TD, Schubert U. 2000. Ubiquitination of HIV-1 and MuLV Gag. Virology 278: 111-121.
33. Ott DE, et al. 1998. Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus. J. Virol. 72: 2962-2968.
34. Ott DE, Coren LV, Sowder RC II, Adams J, Schubert U. 2003. Retroviruses have differing requirements for proteasome function in the budding process. J. Virol. 77: 3384 -3393.
35. Paterson RG, Lamb RA. 1993. The molecular biology of influenza viruses and paramyxoviruses, p 35-73. In Davidson A, Elliot RM (ed), Molecular virology: a practical approach. IRL Oxford University Press, Oxford, United Kingdom.
36. Patnaik A, Chau V, Wills JW. 2000. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. U. S. A. 97: 13069 -13074.
37. Pei Z, Bai Y, Schmitt AP. 2010. PIV5 M protein interaction with host protein angiomotin-like 1. Virology 397: 155-166.
38. Pei Z, Harrison MS, Schmitt AP. 2011. Parainfluenza virus 5 M protein interaction with host protein 14-3-3 negatively affects virus particle formation. J. Virol. 85: 2050 -2059.
39. Peng J, et al. 2003. A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 21: 921-926.
40. Pohl C, Duprex WP, Krohne G, Rima BK, Schneider-Schaulies S. 2007. Measles virus M and F proteins associate with detergent-resistant membrane fractions and promote formation of virus-like particles. J. Gen. Virol. 88: 1243-1250.
41. Putterman D, Pepinsky RB, Vogt VM. 1990. Ubiquitin in avian leukosis virus particles. Virology 176: 633- 637.
42. Randall RE, Young DF, Goswami KK, Russell WC. 1987. Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J. Gen. Virol. 68: 2769 -2780.
43. Ravid D, Leser GP, Lamb RA. 2010. A role for caveolin 1 in assembly and budding of the paramyxovirus parainfluenza virus 5. J. Virol. 84: 9749- 9759.
44. Schmitt AP, He B, Lamb RA. 1999. Involvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5. J. Virol. 73: 8703- 8712.
45. Schmitt AP, Lamb RA. 2004. Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 283: 145-196.
46. Schmitt AP, Leser GP, Morita E, Sundquist WI, Lamb RA. 2005. Evidence for a new viral late domain core sequence, FPIV, necessary for budding of a paramyxovirus. J. Virol. 79: 2988 -2997.
47. Schmitt AP, Leser GP, Waning DL, Lamb RA. 2002. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J. Virol. 76: 3952-3964.
48. Schubert U, et al. 2000. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. U. S. A. 97: 13057-13062.
49. Spidel JL, et al. 2004. Lysines close to the Rous sarcoma virus late domain critical for budding. J. Virol. 78: 10606 -10616.
50. Strack B, Calistri A, Accola MA, Palu G, Göttlinger HG. 2000. A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. U. S. A. 97: 13063-13068.
51. Takimoto T, Portner A. 2004. Molecular mechanism of paramyxovirus budding. Virus Res. 106: 133-145.
52. Timmins J, et al. 2003. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J. Mol. Biol. 326: 493-502.
53. Treier M, Staszewski LM, Bohmann D. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78: 787- 798.
54. Tung CW, Ho SY. 2008. Computational identification of ubiquitylation sites from protein sequences. BMC Bioinformatics 9: 310.
55. Vogt VM. 2000. Ubiquitin in retrovirus assembly: actor or bystander? Proc. Natl. Acad. Sci. U. S. A. 97: 12945-12947.
56. Wang H, Machesky NJ, Mansky LM. 2004. Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release. J. Virol. 78: 1503-1512.
57. Wang YE, et al. 2010. Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. PLoS Pathog. 6: e1001186.
58. Waning DL, Schmitt AP, Leser GP, Lamb RA. 2002. Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5. J. Virol. 76: 9284 -9297.
59. Watanabe H, et al. 2005. Cell-specific inhibition of paramyxovirus maturation by proteasome inhibitors. Microbiol. Immunol. 49: 835- 844.
60. Yang XJ, Seto E. 2008. Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol. Cell 31: 449-461.
61. Yasuda J, Nakao M, Kawaoka Y, Shida H. 2003. Nedd4 regulates egress of Ebola virus-like particles from host cells. J. Virol. 77: 9987-9992.
62. Zhadina M, Bieniasz PD. 2010. Functional interchangeability of late domains, late domain cofactors and ubiquitin in viral budding. PLoS Pathog. 6: e1001153.
63. Zhadina M, McClure MO, Johnson MC, Bieniasz PD. 2007. Ubiquitindependent virus particle budding without viral protein ubiquitination. Proc. Natl. Acad. Sci. U. S. A. 104: 20031-20036.